Vas Narasimhan

Santander Executive Chair Ana Botin sits down with David Rubenstein to discuss the bank's expansion in the US, including its recent acquisition of Webster Financial, and why she sees lack of economic growth as one of the biggest challenges facing the global economy. She also disc ...  Show more

Johnson & Johnson CEO Joaquin Duato says the company has no plans to enter the obesity market, instead focusing on areas such as cancer. He says oncology remains one of J&J's core growth pillars, and highlights dementia as another major challenge for the healthcare industry. Duat ...  Show more

Can AI help us find cures for diseases we've never been able to treat? Nicolai Tangen speaks with Vasant 'Vas' Narasimhan, CEO of Novartis, about pioneering pharmaceutical innovation. They explore breakthrough cell and gene therapies, AI partnerships with leading tech companies, ...  Show more

Can science prevail against this more turbulent backdrop of the Trump administration? Yahoo Finance executive editor Brian Sozzi talks at length with Novartis CEO Vas Narasimhan. Narasimhan has led the drug giant since 2018, doing deals that have expanded the company’s pipeline i ...  Show more

A young boy who picked up life lessons from his grandmother, a woman with a limited education, now heads a globally renowned healthcare company. Vas Narasimhan, the CEO of Novartis, tells us why he keeps a picture of his grandmother on his desk and talks about his Indian American ...  Show more

Moderna CEO Stephane Bancel talks about the Moderna vaccine, drug prices, and future of the company with Bloomberg's Paul Sweeny and Matt Miller. See omnystudio.com/listener for privacy information.